13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 143 holding rows worth $5,629,668,000.
- Accession
- 0000950159-21-000256
- Filer
- CIK 1009258
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 143 entries on the cover page, a total value of $5,629,668,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,629,668,000 with VALUE read as thousands by filing date, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerFlynn Management LLC028-11827
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VIATRIS INC COM | 92556V106 | Stock | 18,824,000 | $268,995,000 | thousands by filing date | |
| SINGULAR GENOMICS SYSTEMS IN | 82933R100 | COM | 9,112,019 | $250,398,000 | thousands by filing date | |
| INVITAE CORP | 46185LAB9 | NOTE 2.000% 9/0 | 163,385,000 | $221,666,000 | thousands by filing date | principal |
| CAREMAX INC | 14171W103 | COM | 16,778,750 | $216,446,000 | thousands by filing date | |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 7,353,792 | $201,567,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771VAB4 | NOTE 1.500%10/0 | 157,390,000 | $156,612,000 | thousands by filing date | principal |
| GLAUKOS CORP | 377322AB8 | BOND | 90,000,000 | $153,534,000 | thousands by filing date | principal |
| NATERA INC | 632307AB0 | BOND | 45,000,000 | $136,309,000 | thousands by filing date | principal |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 80,000,000 | $131,241,000 | thousands by filing date | principal |
| ORGANOGENESIS HOLDINGS INC | 68621F102 | COMMON STOCK | 7,222,127 | $120,032,000 | thousands by filing date | |
| ENVISTA HOLDINGS CORPORATION | 29415FAB0 | BOND | 52,500,000 | $112,018,000 | thousands by filing date | principal |
| NUVASIVE INC | 670704AL9 | BOND | 96,966,000 | $101,298,000 | thousands by filing date | principal |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,933,137 | $83,894,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 1,800,887 | $79,455,000 | thousands by filing date | |
| INSULET CORP | 45784PAK7 | NOTE 0.375% 9/0 | 57,581,000 | $78,182,000 | thousands by filing date | principal |
| APELLIS PHARMACEUTICALS INC | 03753UAB2 | NOTE 3.500% 9/1 | 41,825,000 | $77,769,000 | thousands by filing date | principal |
| ACUTUS MED INC | 005111109 | COM | 4,341,799 | $73,724,000 | thousands by filing date | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 995,000 | $72,565,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 725,000 | $70,557,000 | thousands by filing date | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 1,147,000 | $69,600,000 | thousands by filing date | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 1,362,790 | $61,162,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 3,448,912 | $59,632,000 | thousands by filing date | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 231,776 | $58,653,000 | thousands by filing date | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 5,830,249 | $57,253,000 | thousands by filing date | |
| INSMED INC | 457669AB5 | NOTE 0.750% 6/0 | 50,000,000 | $55,522,000 | thousands by filing date | principal |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 1,138,525 | $54,490,000 | thousands by filing date | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 338,000 | $54,357,000 | thousands by filing date | |
| CONSTELLATION PHARMACEUTICALS INC. | 210373106 | Common Stock | 1,601,427 | $54,128,000 | thousands by filing date | |
| INSMED INC | 457669AA7 | NOTE 1.750% 1/1 | 50,000,000 | $52,525,000 | thousands by filing date | principal |
| QUIDEL CORP | 74838J101 | COM | 409,219 | $52,429,000 | thousands by filing date | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 3,402,384 | $52,125,000 | thousands by filing date | |
| INTERCEPT PHARMACEUTICALS IN | 45845PAA6 | NOTE 3.250% 7/0 | 57,791,000 | $51,920,000 | thousands by filing date | principal |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 2,163,554 | $51,839,000 | thousands by filing date | |
| DFP HEALTHCARE ACQUISITNS CO | 23343Q100 | COM CL A | 5,000,000 | $49,750,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,565,712 | $49,696,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 1,343,560 | $49,188,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464AB6 | NOTE 2.500% 9/1 | 49,064,000 | $47,809,000 | thousands by filing date | principal |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 558,574 | $46,032,000 | thousands by filing date | |
| TABULA RASA HEALTHCARE INC | 873379AA9 | NOTE | 45,000,000 | $45,640,000 | thousands by filing date | principal |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 657,005 | $45,261,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 2,835,000 | $44,821,000 | thousands by filing date | |
| NOVAVAX INC | 670002AB0 | NOTE 3.750% 2/0 | 25,000,000 | $44,647,000 | thousands by filing date | principal |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,552,787 | $44,521,000 | thousands by filing date | |
| APRIA INC | 03836A101 | COMMON STOCK | 1,572,892 | $44,041,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 3,148,977 | $43,456,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 300,000 | $42,459,000 | thousands by filing date | |
| ACCENDRA HEALTH INC | 690732102 | COM | 996,500 | $42,182,000 | thousands by filing date | |
| NUVASIVE INC | 670704AJ4 | NOTE 0.375% 3/1 | 40,000,000 | $39,639,000 | thousands by filing date | principal |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 1,989,625 | $38,957,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 1,794,000 | $37,405,000 | thousands by filing date | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,178,985 | $37,130,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 5,767,409 | $36,392,000 | thousands by filing date | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 3,769,795 | $34,607,000 | thousands by filing date | |
| BIODELIVERY SCIENCES INTL IN | 09060J106 | COM | 9,530,000 | $34,117,000 | thousands by filing date | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 3,577,233 | $33,304,000 | thousands by filing date | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 4,829,069 | $32,162,000 | thousands by filing date | |
| MERIDIAN BIOSCIENCE INC | 589584101 | COMMON STOCK | 1,424,274 | $31,590,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 6,949,416 | $30,508,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 3,811,554 | $28,892,000 | thousands by filing date | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 2,345,959 | $28,761,000 | thousands by filing date | |
| HEALTH CATALYST INC | 42225TAB3 | BOND | 15,000,000 | $28,740,000 | thousands by filing date | principal |
| GRAYBUG VISION INC COM | 38942Q103 | SHS | 5,281,713 | $28,680,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422LAA5 | NOTE 5.000% 7/1 | 18,000,000 | $28,545,000 | thousands by filing date | principal |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,941,492 | $28,356,000 | thousands by filing date | |
| ITAMAR MED LTD SPONSORED ADS | 465437101 | ADR | 1,193,803 | $28,114,000 | thousands by filing date | |
| GRAPHITE BIO INC | 38870X104 | COM | 906,308 | $27,851,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 219,500 | $27,545,000 | thousands by filing date | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 804,000 | $27,465,000 | thousands by filing date | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,044,000 | $26,883,000 | thousands by filing date | |
| XERIS PHARMACEUTICALS INC | 98422L107 | COM | 6,553,398 | $26,672,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 304,000 | $26,384,000 | thousands by filing date | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 3,298,000 | $26,054,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 281,754 | $24,783,000 | thousands by filing date | |
| AVEANNA HEALTHCARE HLDGS INC | 05356F105 | COM | 2,000,000 | $24,740,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 1,238,083 | $24,502,000 | thousands by filing date | |
| BRIGHT HEALTH GROUP INC | 10920V107 | COM | 1,400,000 | $24,024,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 1,020,000 | $23,746,000 | thousands by filing date | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 2,046,958 | $22,946,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,055,192 | $21,980,000 | thousands by filing date | |
| Instil Bio, Inc. | 45783C101 | Common Stock | 1,115,739 | $21,556,000 | thousands by filing date | |
| MONTES ARCHIMEDES ACQUISITIO | 612657205 | UNIT 09/30/2025 | 2,000,000 | $21,320,000 | thousands by filing date | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 1,297,797 | $21,232,000 | thousands by filing date | |
| NEVRO CORP | 64157FAC7 | NOTE 2.750% 4/0 | 12,000,000 | $20,863,000 | thousands by filing date | principal |
| OUTSET MEDICAL INC | 690145107 | COM | 400,622 | $20,023,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 1,032,757 | $19,240,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 818,980 | $18,648,000 | thousands by filing date | |
| STEREOTAXIS INC | 85916J409 | COMMON STOCK | 1,843,000 | $17,767,000 | thousands by filing date | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 700,000 | $17,465,000 | thousands by filing date | |
| QUANTUM SI INC | 74765K105 | COM CL A | 1,400,000 | $17,164,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 787,000 | $16,558,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 714,285 | $16,307,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366JAB7 | NOTE | 14,527,000 | $15,558,000 | thousands by filing date | principal |
| BLUEBIRD BIO INC | 09609G100 | COM | 480,300 | $15,360,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 1,816,221 | $14,530,000 | thousands by filing date | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 360,966 | $14,096,000 | thousands by filing date | |
| MEDAVAIL HOLDINGS INC | 58406B103 | COM | 1,142,552 | $13,996,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 560,132 | $13,841,000 | thousands by filing date | |
| BIOVENTUS INC | 09075A108 | COM CL A | 778,567 | $13,703,000 | thousands by filing date | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 300,000 | $13,311,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 825,937 | $13,223,000 | thousands by filing date | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $13,144,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,601,000 | $12,984,000 | thousands by filing date | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 1,047,599 | $12,770,000 | thousands by filing date | |
| CONVEY HEALTH SOLUTIONS HLDG | 21258C108 | CMN | 1,100,000 | $12,518,000 | thousands by filing date | |
| AMERICAN WELL CORP | 03044L105 | CL A | 991,115 | $12,468,000 | thousands by filing date | |
| AGILON HEALTH INC | 00857U107 | COM | 300,000 | $12,171,000 | thousands by filing date | |
| GH RESEARCH PLC ORDINARY SHARES | G3855L106 | Stock | 555,416 | $12,069,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 400,000 | $11,200,000 | thousands by filing date | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 400,000 | $11,144,000 | thousands by filing date | |
| SARISSA CAPITAL ACQUISITN CO | G7823W128 | UNIT 10/23/2027 | 1,000,000 | $10,420,000 | thousands by filing date | |
| BIOATLA INC | 09077B104 | COM | 245,381 | $10,399,000 | thousands by filing date | |
| EUCRATES BIOMEDICAL ACQU COR | G3141W114 | UNIT 10/23/2027 | 1,000,000 | $10,200,000 | thousands by filing date | |
| SENIOR CONNECT ACQUISITN COR | 81723H207 | UNIT 12/09/2023 | 1,000,000 | $10,120,000 | thousands by filing date | |
| REVOLUTION HEALTHCAR AQ CORP | 76155Y207 | UNT | 1,000,000 | $10,080,000 | thousands by filing date | |
| MEDTECH ACQUISITION CORP | 58507N204 | UNIT 12/18/2025 | 1,000,000 | $10,020,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 2,827,000 | $9,895,000 | thousands by filing date | |
| CM LIFE SCIENCES II INC | 125842203 | UNIT 02/25/2028 | 600,000 | $8,070,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 350,000 | $7,945,000 | thousands by filing date | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 849,300 | $7,924,000 | thousands by filing date | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 271,191 | $7,588,000 | thousands by filing date | |
| TURMERIC ACQUISITION CORP | G9127T116 | UNT | 750,000 | $7,545,000 | thousands by filing date | |
| IGNYTE ACQUISITION CORP | 45175H205 | UNIT 01/05/2026 | 725,000 | $7,265,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 83,846 | $6,542,000 | thousands by filing date | |
| DELCATH SYSTEMS INC | 24661P807 | COMMON STOCK | 500,000 | $6,305,000 | thousands by filing date | |
| TALKSPACE INC | 87427V103 | COM | 750,000 | $6,233,000 | thousands by filing date | |
| BENEFITFOCUS INC | 08180DAB2 | BOND | 6,500,000 | $6,130,000 | thousands by filing date | principal |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 200,000 | $5,692,000 | thousands by filing date | |
| CONSONANCE HFW ACQUISITION C | G2445M129 | UNIT 99/99/9999 | 500,000 | $5,200,000 | thousands by filing date | |
| ORION ACQUISITION CORP | 68626A207 | UNIT 02/19/2026 | 500,000 | $4,960,000 | thousands by filing date | |
| INTERSECT ENT INC | 46071F103 | COM | 255,456 | $4,366,000 | thousands by filing date | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 464,252 | $3,993,000 | thousands by filing date | |
| BIOMEA FUSION INC | 09077A106 | CMN | 248,447 | $3,878,000 | thousands by filing date | |
| BUTTERFLY NETWORK INC | 124155110 | *W EXP 02/12/202 | 733,333 | $3,542,000 | thousands by filing date | |
| CAREMAX INC | 14171W111 | *W EXP 06/08/202 | 672,000 | $3,172,000 | thousands by filing date | |
| ACHILLES THERAPEUTICS PL-ADR | 00449L102 | COM | 301,431 | $2,951,000 | thousands by filing date | |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 2,500,000 | $2,452,000 | thousands by filing date | principal |
| CEREVEL THERAPEUTICS HLDNG I | 15678U102 | *W EXP 06/09/202 | 166,666 | $2,398,000 | thousands by filing date | |
| DFP HEALTHCARE ACQUISITNS CO | 23343Q118 | *W EXP 03/31/202 | 1,250,000 | $2,163,000 | thousands by filing date | |
| QUANTUM SI INC | 74765K113 | *W EXP 06/10/202 | 333,333 | $1,253,000 | thousands by filing date | |
| METACRINE INC | 59101E103 | COM | 277,469 | $1,054,000 | thousands by filing date | |
| NUVATION BIO INC | 67080N119 | WARR | 166,666 | $433,000 | thousands by filing date | |
| LUMOS PHARMA INC | 55028X109 | COM | 33,117 | $331,000 | thousands by filing date | |
| WINDTREE THERAPEUTICS INC | 97382D303 | COM | 20,148 | $46,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950159-21-000256 | this filing | 2021-08-16 | acceptance time not in the bulk data set |